Elevance Health Stock Plummets 19.76% in Three Days as Trading Volume Drops to 89th Rank

On July 21, 2025, Elevance Health (ELV) experienced a significant decline, with its trading volume dropping by 57.92% to 9.96 billion, ranking 89th in the day's market activity. The stock price fell by 0.23%, marking the third consecutive day of decline, with a total decrease of 19.76% over the past three days.

Argus Research has downgraded Elevance Health from a 'Buy' to a 'Hold' rating, citing ongoing pressures on the company's profit margins. The firm attributes this to higher medical cost trends in its ACA marketplace and Medicaid businesses. Argus expects the path to margin recovery to take longer than previously anticipated, leading to reduced EPS estimates for both 2025 and 2026.

Baird R W also adjusted its rating for Elevance Health, lowering it from a 'strong-buy' to a 'hold' in a report issued on April 15th. This move reflects the increasing challenges the company faces due to rising medical costs, which are impacting its profit margins.